Join us on sample date
Since 1955, the CF Foundation has added decades to the lives of people with the disease. These gains are the direct result of advances in treatment and care made possible through the Foundation’s innovative business model, called venture philanthropy.
Through venture philanthropy, the CF Foundation has raised and invested hundreds of millions of dollars to fuel CF-specific drug development programs and encouraged pharmaceutical companies to invest in rare-disease research.
The results of these bold investments have been astonishing. Virtually every approved CF drug available today was made possible with CF Foundation support, including the newly approved triple-combination modulator therapy called Trikafta . Each new breakthrough is a building block that brings us closer to our ultimate goal: a cure for all people with CF.
CF is a complex disease requiring complex care and treatment. Thank you for partnering with the CF Foundation to bring an end to CF. We will not stop until it’s done!